Sign in Create account

BDH Industries Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 524828
₹495.15
▼ -5.15 (-1.03%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
65/100
Moderate
Valuation
62/100
Fairly Valued
Momentum
49/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹285 Cr
PE (TTM)
24.3
Industry median 36.1 (152 companies)
Price to Book
3.7
PEG (TTM)
1.1
Institutions holding %
0.28%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
44.3
Free Cash Flow
₹-2 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
49.21%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
11.81%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
44.77%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
49.04%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
20.16%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
4.00
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.03
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
239.39
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
12.17%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
16.57%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
16.57%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
10.52%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
19.28%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
13.54%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.03)
  • No Return on equity is 15% or more (13.5%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Overvalued (above its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.0%
Low 490.3000 · High 508.9500
1W return
-1.8%
Low 482.0000 · High 513.7000
1M return
-1.9%
Low 476.0000 · High 584.0000
52W return
44.3%
Low 476.0000 · High 584.0000
Lifetime High ₹568.3500 (Aug. 7, 2026)
Lifetime Low ₹6.7000 (March 24, 2009)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
498.4
10D
500.5
20D
503.0
50D
478.8
100D
426.0
200D
328.4

Delivery and volume

Day avg. delivery
82.8%
Week avg. delivery
72.9%
Month avg. delivery
82.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

498.13
Pivot
First resistance505.97
Second resistance516.78
Third resistance524.62
First support487.32
Second support479.48
Third support468.67
Day RSI47.7
Day MFI25.7
Day MACD0.54
Day MACD signal4.00

Beta

1M-0.30
3M0.15
1Y0.15
3Y0.72

Price change analysis

↓ -1.9%
Over 1 Month
LowHigh
476.00584.00
↑ 44.3%
Over 3 Months
LowHigh
476.00584.00
↑ 44.3%
Over 6 Months
LowHigh
476.00584.00
↑ 44.3%
Over 1 Year
LowHigh
476.00584.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 24.3 (own history: 16.4–21.3)
Overvalued (above its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹22 Cr
Net profit (June 30, 2026)
₹3 Cr
Basic EPS (June 30, 2026)
₹4.7300

Ranks #111 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter49.70%
  • FII/FPI0.28%
  • Public50.02%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 49.70% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.28% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 58 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
11 Sep 2025 F3 ADVISORS PRIVATE LIMITED Bulk Sell 40,119 362.5700 BSE
11 Sep 2025 F3 ADVISORS PRIVATE LIMITED Bulk Buy 49,381 369.7800 BSE
22 Nov 2024 RAJESH MADHAVAN UNNI(HUF) Bulk Buy 38,825 333.2600 BSE
5 Feb 2024 VRAMATH FINANCIAL SERVICES PRIVATE LIMTED Bulk Buy 36,723 241.8000 BSE
1 Jan 2024 DEBASHREE DEY Bulk Buy 30,000 262.8900 BSE
1 Jan 2024 S.HARSHA VIJAY Bulk Buy 30,000 244.6100 BSE
1 Jan 2024 RAJESH MADHAVAN UNNI(HUF) Bulk Sell 93,242 262.6700 BSE
15 Dec 2023 VRAMATH FINANCIAL SERVICES PRIVATE LIMTED Bulk Buy 76,000 189.3300 BSE
15 Dec 2023 VRAMATH INVESTMENT CONSULTANCY PVT LTD Bulk Sell 76,000 189.3300 BSE
21 Aug 2023 RAJESH MADHAVAN UNNI(HUF) Bulk Buy 29,150 211.5700 BSE

All bulk and block deals →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.03)
  • Comfortable interest coverage (239.4x)
  • Strong revenue growth YoY (20.2%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about BDH Industries Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.